grant

Neuromodulatory regulation of synaptic plasticity in spinal nociceptive circuits

Organization UNIVERSITY OF CINCINNATILocation CINCINNATI, UNITED STATESPosted 1 Apr 2022Deadline 31 Mar 2027
NIHUS FederalResearch GrantFY20250-11 years old21+ years oldAdultAdult HumanAgonistAnalgesia TestsBody TissuesBrainBrain Nervous SystemCell Communication and SignalingCell SignalingChildChild YouthChildren (0-21)DataDopamineDopamine ReceptorDrugsE-stimERK 1ERK MAP KinasesERK1ERK1 KinaseElectric StimulationElectrophysiologyElectrophysiology (science)EncephalonEnvironmentExtracellular Signal Regulated KinasesExtracellular Signal-Regulated Kinase 1Extracellular Signal-Regulated MAP KinasesFosteringG Protein-Complex ReceptorG Protein-Coupled Receptor GenesG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGPCRGPCR SignalingGRIK1 gene productGenerationsGeneticHumanHydroxytyramineImmunohistochemistryImmunohistochemistry Cell/TissueImmunohistochemistry Staining MethodIn Situ HybridizationIn VitroInfantInjuryIntervention StrategiesIntracellular Communication and SignalingInvestigationKnowledgeLearningLifeLinkLong-Term PotentiationLong-term painMAP Kinase 3MAPK ERK KinasesMAPK3MAPK3 Mitogen-Activated Protein KinaseMAPK3 geneMediatingMedicationMiceMice MammalsMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase 3 GeneModern ManMolecularMurineMusNeonatalNerve CellsNerve UnitNeural CellNeurocyteNeuromodulatorNeuronsNeurophysiology / ElectrophysiologyNociceptionNociception TestsOtomyOutcomeOutputP44ERK1PSTkinase p44mpkPainPain AssessmentPain MeasurementPain measurePainfulPathway interactionsPersistent painPharmaceutical PreparationsProtocolProtocols documentationPublic HealthReceptor ActivationReceptor ProteinRegulationRelaxationResearchRodentRodentiaRodents MammalsSensoryShapesSignal PathwaySignal TransductionSignal Transduction SystemsSignalingSpinalSurgical InjuriesSurgical incisionsSynapsesSynapticSynaptic plasticityTestingThreonine/Tyrosine Protein KinaseTimeTissuesTransmissionWorkadulthoodantagonismantagonistbehavior measurementbehavioral measurebehavioral measurementbiological signal transductionchronic painconstant paindesigndesigningdorsal horndrug/agentdruggable targetelectrophysiologicalelectrostimulationextracellular signal related kinasegene manipulationgenetic manipulationgenetically manipulategenetically perturbin situ Hybridization Geneticsin situ Hybridization Staining Methodincisioninhibitorinjuriesinjury to tissueinnovateinnovationinnovativeinsightkidslasting painmetabotropic glutamate receptor 5multidisciplinaryneonatal injuryneonatal surgeryneural controlneural regulationneuromodulationneuromodulatoryneuronalneuroregulationnociceptivenovelon-going painongoing painp44 MAPKpain assaypain perceptionpain sensationpain sensitivitypainful sensationpathwaypermissivenesspharmacologicpostsynapticpresynapticpreventpreventingreceptorsynapsetissue injurytransmission processyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary/Abstract
Long-term potentiation (LTP) of primary afferent synapses onto spinal projection neurons (PNs) has

been linked to increased pain sensitivity. The timing rules controlling the generation of LTP in adult PNs can

be persistently relaxed by neonatal tissue damage, which likely contributes to the ability of early life injury to

‘prime’ nociceptive circuits and thereby exacerbate pain after subsequent insult. In the brain, the temporal

window governing this spike timing-dependent plasticity (STDP) is strongly regulated by G protein-coupled

receptor (GPCR) signaling evoked by neuromodulators such as dopamine (DA). This raises the possibility that

neonatal injury facilitates LTP at primary afferent synapses onto adult PNs, and thereby promotes persistent

pain, via long-term changes in spinal neuromodulatory signaling. Unfortunately, it remains unknown how

GPCRs influence STDP at sensory synapses onto PNs. As a result, the cellular and molecular mechanisms

underlying the increased amplification of ascending nociceptive transmission by the adult dorsal horn during

the primed state are poorly understood. The objective of this application is to identify the neuromodulatory

signals that promote the activity-dependent strengthening of sensory synapses onto the key output neurons of

the spinal nociceptive circuit and contribute to the priming of developing pain pathways after early life injury.

The central hypothesis is that ‘non-Hebbian’ LTP at sensory synapses onto spinal PNs is enabled by D1-like

(i.e. D1/D5) dopamine receptor activation, occurring in concert with mGluR5-dependent intracellular Ca2+

release and extracellular signal-regulated kinase (ERK) signaling, which is essential for neonatal priming. The

rationale of the proposed research is that these studies will identify novel molecular strategies to reduce the

signaling gain of the spinal nociceptive network. Guided by strong preliminary data, the central hypothesis will

be tested by pursuing the following specific aims: (1) Elucidate how DA receptor activation shapes STDP in

PNs; (2) Identify the signaling pathways which cooperate with DA receptors to facilitate LTP in PNs; and (3)

Identify the neuromodulators which mediate the priming of spinal nociceptive circuits following neonatal tissue

damage. These aims will be accomplished by using a multidisciplinary experimental approach that includes

electrophysiological characterization of STDP in PNs combined with both reflexive and non-reflexive behavioral

measures of pain. The proposed work is innovative because it will be the first to demonstrate that DA signaling

dictates the timing rules governing the plasticity of sensory synapses onto spinal PNs. The outcome of these

investigations will be the identification of new spinal mechanisms that augment nociceptive transmission to the

brain, and the demonstration that aberrant neuromodulation contributes to the persistent sensitization of spinal

nociceptive circuits after early tissue damage. Thus the proposed research is significant because it will provide

knowledge needed to design novel interventional strategies to disrupt spinal LTP as a means to alleviate

chronic pain and to minimize the long-term consequences of neonatal tissue injury for the developing CNS.

Grant Number: 5R37NS122141-04
NIH Institute/Center: NIH

Principal Investigator: Mark Baccei

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →